CNST - Constellation Pharmaceuticals EPS beats by $0.02 March, 10 2020 04:15 PM Constellation Pharmaceuticals Inc. Constellation Pharmaceuticals (NASDAQ:CNST): Q4 GAAP EPS of -$0.69 beats by $0.02.More news on: Constellation Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...